Unknown

Dataset Information

0

Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19.


ABSTRACT: Neurological long-term sequelae are increasingly considered an important challenge in the recent COVID-19 pandemic. However, most evidence for neurological symptoms after SARS-CoV-2 infection and central nervous system invasion of the virus stems from individuals severely affected in the acute phase of the disease. Here, we report long-lasting cognitive impairment along with persistent cerebrospinal fluid anti-SARS-CoV-2 antibodies in a female patient with unremarkable standard examination 6 months after mild COVID-19, supporting the implementation of neuropsychological testing and specific cerebrospinal fluid investigation also in patients with a relatively mild acute disease phase.

SUBMITTER: Borsche M 

PROVIDER: S-EPMC8214919 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3740054 | biostudies-literature
| S-EPMC3175115 | biostudies-literature
| S-EPMC5714663 | biostudies-literature
| S-EPMC6465729 | biostudies-literature
| S-EPMC8533797 | biostudies-literature
| S-EPMC6342191 | biostudies-literature
| S-EPMC7190828 | biostudies-literature
| S-EPMC4255518 | biostudies-literature
| S-EPMC6991300 | biostudies-literature
| S-EPMC10793182 | biostudies-literature